Request Call Back

Contact Us

Case Review Form
*    Denotes required field.

Describe accident or indicate name of drug or device

   * First Name 

   * Last Name 

   * Email 


   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Strykers Cervical Spine Device Recalled

Defect Drives FDA's Class 1 Recall of Stryker's Oasys Midline Occiput Plate

Defect Drives FDA's Class 1 Recall of Stryker's Oasys Midline Occiput Plate

Defect Drives FDA's Class 1 Recall of Stryker's Oasys Midline Occiput Plate

The U.S. Food and Drug Administration (FDA) has issued a Class 1 recall – the most serious of all recall classes – for the Stryker Oasys Midline Occiput Plate, a device used in cervical spinal fusion surgery, based on reports of post-operative fracture of a key component of the device.

The FDA first revealed the recall in an Aug. 29 safety alert to the public. The recall was based on reports that the pin connecting the tulip head to the plate body of the Stryker Oasys Midline Occiput Plate has a tendency to break following surgery. Such a fracture could lead to destabilization of the plate, and revision surgery may be required, the FDA warned in the safety alert. A host of dangerous side effects also are possible.

Revision Surgery, Blood Loss, Nerve Injury Among Potential Adverse Results

Those implanted with this device face the possibility of serious adverse health consequences, including blood loss and nerve injury, as well as the need for revision surgery to replace the fractured implant, noted the FDA's safety alert.

Class I recalls are the most serious – involving situations “in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death,” the FDA noted in the safety alert. If a patient begins suffering from symptoms such as pain, weakness, or numbness, “urgent evaluation is needed,” the FDA said in the safety alert, adding that “for patients who have had a revision surgery, Stryker recommends routine post-operative care and follow-up.”

The FDA also noted that the Oasys Midline Occiput Plate is part of the Oasys System, which is used in spinal surgery to promote fusion and provide stabilization at the junction between the occipital bone and the vertebrae in the cervical and thoracic spine.

On July 22, the Australian Government's Department of Health and Ageing issued a hazard alert regarding the Oasys Midline Occipital Plate.

Legal Help for Patients Who Have Been Implanted with Stryker's Oasys Midline Occiput Plate

If you or a loved one have been implanted with Stryker's Oasys Midline Occiput Plate during cervical spine fusion surgery, you may have valuable legal rights. To find out more, please fill out our online form or contact one of our experienced personal injury lawyers today at 1-800-YOURLAWYER (1-800-968-7529).


Strykers Cervical Spine Device RecalledRSS Feed

Stryker Oasys Spine Device Recall One in a Stream of Issues for the Device Maker

Nov 5, 2013
By Gary Falkowitz Undergoing spinal surgery is a frightening and worrisome prospect for patients, and patients agree to these typically complex procedures believing the medical device products being used in their surgeries—and in their bodies—are safe and effective. In the case of the Stryker Orthopedics’ Oasys Midline Occiput Plate, that was not so. The device has been recalled in the United Sates and the U.S. Food and Drug Administration (FDA) has deemed the...

More Strykers Cervical Spine Device Recalled News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo